introduction In the world of trading, getting into real markets quickly is tempting. But before risking real money,...
Search in blog
Blog categories
- FAQ – Your guide through the world of finance and technical facilities (1) click
- Daytrading Almanac (25) click
- Press release (22)
- Educational (23) click
- Projects (7)
- Chart analysis (33) click
- Trading bots for cTrader (11)
- AI in trading (5)
- Trading Strategien (11)
- Trading signals and stock market letters (38)
Latest posts
A journey marked by success and an unexpected lesson The last three months of my trading journey felt like a winning...
A 1:500 trading account offers higher leverage, which opens up huge profit opportunities for experienced traders. But...
The AI Finance Association Europe aims to provide its members with access to the best financial services and trading...
The Dangers of One-Sidedness in Trading Are you new to trading or looking to expand your skills? 🚀 It may be...
Popular posts
Featured posts
Photo gallery
No featured images
Archived posts
Top authors
-
Christian Lill 56 Posts View posts
-
-
-
-
Eli Lilly - Range breakout sets new all-time highs
Eli Lilly is a pharmaceutical company focused on neuroscience, endocrinology, oncology and immunology. Lilly's key products include Alimta and Verzenio for cancer; Jardiance, Trulicity, Humalog and Humulin for diabetes; and Taltz and Olumiant for immunology.
Chart technical outlook
The pharmaceutical giant is setting new momentum today with a new record high. The share is in the process of breaking out of the recently established trading range upwards. The company's securities have been trading below the record level and resistance of USD 802 for three months. Today the share was able to make a dynamic attempt to break out of this upwards.
In further development, new record levels of around USD 890 could be established. In chart terms, the former height of the trading range can be shown upwards based on market technology.